logo
Share SHARE
FONT-SIZE Plus   Neg

Pre-market Movers For April 3 (AAPL, BNNY, CAVM, NFLX)

Gainers:

Apple Inc. (AAPL) is gaining over 1 percent to $625.30. The European Commission has opened two formal antitrust investigations against Motorola Mobility Holdings, Inc. (MMI), following complaints by Apple and Microsoft (MSFT). The Commission will assess whether Motorola Mobility has abusively, and in contravention of commitments it gave to standard setting organisations, used certain of its standard essential patents to distort competition in the Internal Market in breach of EU antitrust rules.

Annies Inc. (BNNY), which went public last week, is rising 8 percent to $37.49.

Decliners:

Cavium, Inc. (CAVM) is falling over 1 percent to $30.11. The company announced that financial results for its first quarter of 2012 will be below its previous outlook. In addition, the company currently expects first quarter revenue to be approximately 6 percent to 7 percent lower sequentially.

Netflix, Inc. (NFLX) is falling 3 percent to $110.64.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Snack and beverage giant Pepsico Inc. reported Thursday significantly higher profit in its third quarter, reflecting the absence of last year's hefty Venezuelan impairment charges, despite weak revenues. Core earnings and revenues beat market estimates. Further, the company lifted its fiscal 2016 forecast on its performance and outlook for the fourth quarter. Almost 71 percent of Americans say they don't save enough for their retirement, while around 54 percent believe they will never pay off their debt fully, according to a new national survey. The latest survey, commissioned by Experian together with Get Rich Slowly and other top U.S. personal finance... The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects.
comments powered by Disqus
Follow RTT